Strahlentherapie und Onkologie

Papers
(The TQCC of Strahlentherapie und Onkologie is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Stereoscopic X-ray image and thermo-optical surface guidance for breast cancer radiotherapy in deep inspiration breath-hold25
Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients24
Neoadjuvante Therapie des lokal fortgeschrittenen Plattenepithelkarzinoms des Ösophagus24
Treatment of COVID-19 pneumonia with low-dose radiotherapy plus standard of care versus standard of care alone in frail patients24
Reply to Letter to the Editor: Reply to comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy22
Dosimetric advantages for cardiac substructures in radiotherapy of esophageal cancer in deep-inspiration breath hold21
Longer time to testosterone recovery impacts favorably on outcomes for prostate cancer following androgen deprivation and radiotherapy21
Abnormal visual and olfactory sensations during radiation therapy: a prospective study21
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose20
Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie19
Assoziation von alterstypischen strukturellen Veränderungen des Gehirns und Ganzhirnbestrahlung19
A novel lung-avoidance planning strategy based on 4DCT ventilation imaging and CT density characteristics for stage III non-small-cell lung cancer patients19
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial18
Automated contouring for breast cancer radiotherapy in the isocentric lateral decubitus position: a neural network-based solution for enhanced precision and efficiency18
Körperstereotaktische Bestrahlung im Vergleich zu moderner Chirurgie zur Behandlung des NSCLC im Stadium I17
Impact of comorbidity scores and lifestyle factors in curative radiotherapy in laryngeal cancer16
Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours16
Dosiseskalation bei der Radiotherapie inoperabler Ewing-Tumoren16
Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma15
The impact of nutritional counseling on thyroid disorders in head and neck cancer patients after (chemo)radiotherapy: results from a prospective interventional trial15
Langzeitergebnisse der ORATOR-Studie: Radiotherapie versus transorale roboter-assistierte Chirurgie in der Primärtherapie des Oropharynxkarzinoms14
Teaching communication skills in medical education14
Ein neuer Standard zeichnet sich ab: PD-1-Erhaltungstherapie nach neoadjuvanter Radiochemotherapie und kurativer Resektion bei Ösophagus- und AEG-Karzinomen (CheckMate 577)13
Risikostandardisierte Mortalitätsraten übertreffen als Qualitätsindikator die typischen „Mindestzahlen“ in der onkologischen Chirurgie – ein neuer Blick auf Krankenhauszentralisationen mithilfe nation13
Practice of radiation therapy for anal cancer in Austria—a survey on behalf of the Austrian radiation oncology society gastrointestinal tumor group (ÖGRO-GIT)13
26th Annual SASRO Meeting13
Impact of prescription isodose level and collimator selection on dose homogeneity and plan quality in robotic radiosurgery13
The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting13
Impact of postoperative radiotherapy on the outcomes of resected adrenocortical carcinoma—a real-world, population-based study13
Comparison of integral doses to normal tissue and organs at risk between interstitial high-dose-rate brachytherapy and modern external-beam radiotherapy techniques in breast and head and neck cancer p12
Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment12
Changes in serum uric acid, serum uric acid/serum creatinine ratio, and gamma-glutamyltransferase might predict the efficacy of neoadjuvant chemoradiotherapy in patients with locally advanced rectal c12
Can interventional radiotherapy (brachytherapy) be an alternative to surgery in early-stage oral cavity cancer? A systematic review12
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer12
Synthetic CTs for MRI-only brain RT treatment: integration of immobilization systems12
Radiotherapy for vertebral hemangioma: the single-center experience of 80 patients12
Einfluss der Fraktionierung (1 × 24 Gy vs. 3 × 9 Gy) auf onkologische Endpunkte bei der SBRT von Oligometastasen12
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB t12
Value of PET imaging for radiation therapy11
Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center11
Nintedanib zur Therapie der radiogenen Pneumonitis11
Radio(chemo)therapy in anaplastic thyroid cancer—high locoregional but low distant control rates—a monocentric analysis of a tertiary referral center11
Cardiac metastasis in uterine cervical cancer11
Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy11
Impact of dose volume parameters and clinical characteristics on radiation-induced acute oral mucositis for head and neck cancer patients treated with carbon-ion radiotherapy dose volume outcome analy11
Potential Single Nucleotide Polymorphisms markers for radiation dermatitis in head and neck cancer patients: a meta-analysis11
Stereotaktische Radiotherapie plus Nivolumab bei NSCLC11
Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO)11
DEGRO 2023 Abstractbuch10
Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature10
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy10
German radiation oncology’s next generation: a web-based survey of young biologists, medical physicists, and physicians—from problems to solutions10
Deutsche Gesellschaft für Radioonkologie (DEGRO) mahnt stationäre strahlentherapeutische Versorgung an10
Correction to: Innovative radiation oncology Together—Precise, Personalized, Human10
Radio(chemo)therapy in anal cancer: evaluation of sex-specific disparities across AJCC stages10
Unerwünschte Ereignisse bei Patienten unter Immuntherapie nach Strahlentherapie – gepoolte Analyse von Studien aus der Datenbank der US Food and Drug Administration10
Trends in radiotherapy inpatient admissions in Germany: a population-based study over a 10-year period10
Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancer10
Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma10
Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis9
Thymic tumors: radiotherapy experience for single institute9
Kein Vorteil einer Erhaltungstherapie mit Afatinib in der adjuvanten Therapie von Kopf-Hals-Tumoren9
Intensity modulated radiation therapy in prostate cancer—Better survival with higher total dose?9
First clinical experience with a novel, mobile cone-beam CT system for treatment quality assurance in brachytherapy9
Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites9
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer9
Determinants of radiation dose to immune cells during breast radiotherapy9
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis9
Surface-guided DIBH radiotherapy for left breast cancer: impact of different thresholds on intrafractional motion monitoring and DIBH stability9
Abstracts DEGRO 20218
Multidisciplinary treatment is necessary in glioblastoma with extracerebral metastases8
Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?8
Multimodale Therapieansätze beim Hochrisikoprostatakarzinom – was wann?8
The benefit of intravenous immune globulin in the treatment of delayed radiation myelopathy8
Die Bedeutung der präoperativen Immunhistochemie bei Patientinnen mit Endometriumkarzinomen – welche Parameter sind entscheidend?8
Die intraoperative Strahlentherapie (IORT) als mögliche Alternative zum vollständigen Verzicht auf eine adjuvante Radiotherapie nach brusterhaltender Operation bei älteren Patientinnen mit niedriger R8
Körperstereotaktische Bestrahlung als „Erstlinientherapie“ des oligometastasierten Nierenzellkarzinoms8
Stellenwert einer „targeted therapy“ beim EGFR-mutierten Lungenkarzinom nach erfolgter Radiochemotherapie8
Analysis of patients with parotid recurrence after parotid-sparing IMRT for nasopharyngeal carcinoma: case series and review of the literature8
Ampelopsis japonica enhances the effect of radiotherapy in non-small cell lung cancer7
Evaluation of treatment-associated eye toxicity after irradiation in childhood and adolescence—results from the Registry of the Evaluation of Side Effects after Radiotherapy in Childhood and Adolescen7
Neoadjuvant chemoradiotherapy in combination with deep regional hyperthermia followed by surgery for rectal cancer: a systematic review and meta-analysis7
Phase-II-Studie zur Therapiedeeskalation bei HPV-assoziierten Oropharynxkarzinomen. Kommentar II7
Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy7
Prophylaktische Hirnbestrahlung mit und ohne Hippocampusschonung beim kleinzelligen Bronchialkarzinom (PREMER) – eine randomisierte Phase-III-Studie7
YB-1 activating cascades as potential targets in KRAS-mutated tumors7
Patient- and clinician-based evaluation of large language models for patient education in prostate cancer radiotherapy7
Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis7
Long-term survival in patients with brain metastases—clinical characterization of a rare scenario7
Kein Vorteil für die lokale Kontrolle nach Dosiseskalation der Strahlentherapie bei Patienten mit Ösophaguskarzinom nach einer definitiven Radiochemotherapie: randomisierte Phase-III-Studie ARTDECO7
CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis7
Effect of simultaneous integrated boost concepts on photoneutron and distant out-of-field doses in VMAT for prostate cancer7
Isodoses—a set theory-based patient-specific QA measure to compare planned and delivered isodose distributions in photon radiotherapy7
Low-dose radiotherapy for greater trochanteric pain syndrome—a single-centre analysis7
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities6
Keine abskopalen Effekte bei Kombination von Immuntherapie und stereotaktischer Radiotherapie bei Merkel-Zell-Karzinomen6
Chemoradiotherapy for untreated Masaoka–Koga stage IVB thymic carcinoma: a single-center retrospective study6
Prädiktion der pathologischen Komplettremission beim Ösophaguskarzinom nach neoadjuvanter Radiochemotherapie mittels FDG-PET/CT und diffusionsgewichteter MRT6
Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy6
Staphylococcus-aureus-Kolonisation als Risikofaktor der akuten Strahlenreaktion an der Haut6
CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer: a single institute pilot study6
Pulmonary artery intimal sarcoma: Case report of a patient managed with multimodality treatment and a comprehensive literature review6
Survival outcomes, hematologic complications and growth impairment after sequential chemoradiotherapy in intracranial NGGCTs: a retrospective study6
Organerhaltende Behandlung bei nodal-positiven Harnblasenkarzinomen6
4DCT ventilation function image-based functional lung protection for esophageal cancer radiotherapy6
Olaparib bei biochemischem Rezidiv des High-risk-Prostatakarzinoms nach Prostatektomie6
Assessment and validation of glottic motion using cone-beam CT and real-time cine MRI6
Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Associati6
Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy6
Lokale Strahlentherapie der Prostata mit Samenblasenbasis allein oder mit elektiver Bestrahlung pelviner Lymphknotenstationen beim Hochrisiko-Prostatakarzinom?6
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking6
Radiotherapy for painful shoulder syndrome: a retrospective evaluation6
Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma6
Vergleich der radikalen Zystektomie mit der trimodalen Therapie beim muskelinvasiven Harnblasenkarzinom6
Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway6
Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis6
Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma6
High radiation dose in chemoradiotherapy followed by immunotherapy with durvalumab in patients with stage III non-small cell lung cancer does not increase risk for pneumonitis5
Postoperative Radiotherapie für pT1–2-N0-Zungenkarzinome: Zeit für ein Umdenken?5
Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival5
MicroRNA-29b regulates the radiosensitivity of esophageal squamous cell carcinoma by regulating the BTG2-mediated cell cycle5
Neoadjuvant chemoradiotherapy for locally advanced rectal cancer with peritumoral abscesses and fistulas5
Chemotherapiebedingte kognitive Beeinträchtigungen bei Mammakarzinompatientinnen – Risikofaktoren und Therapie5
The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review5
Application of frozen Thiel-embalmed specimens for radiotherapy delineation guideline development: a method to create accurate MRI-enhanced CT datasets5
Excellent long-term pain response and local control following postoperative radiotherapy in patients with multiple myeloma5
A new GPU-based Monte Carlo code for helium ion therapy5
Sekundärmalignome nach Ganzkörperbestrahlung pädiatrischer Leukämiepatienten – eine kritische Re-Evaluation der multizentrischen ALL-SCT-BFM-2003-Studie5
Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients5
Impact of the COVID-19 pandemic on training conditions and education in oncologic disciplines: a survey-based analysis5
Usability and usefulness of (electronic) patient identification systems—A cross-sectional evaluation in German-speaking radiation oncology departments5
Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors5
Digital redesign of the radiotherapy course for medical students with a blended learning approach5
Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences5
Konditionierung mit Ganzkörperbestrahlung oder Chemotherapie bei ALL im Kindesalter5
Intraoperative Teilbrustbestrahlung mit Elektronen (ELIOT) vs. konventionelle Ganzbrustbestrahlung beim invasiven Mammakarzinom im frühen Stadium nach brusterhaltender Operation: Langzeitdaten einer k5
Mepitel-Film zur Prävention der Radiodermatitis bei Brustbestrahlung5
FBXL18 increases cell proliferation and reduces cell radiosensitivity in esophageal squamous cell carcinoma5
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost5
The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients5
CBCT-based online adaptive radiotherapy of the prostate bed: first clinical experience and comparison to nonadaptive conventional IGRT5
Impact of antibiotic use before definitive concurrent chemoradiation in patients with locally advanced non-small cell lung cancer5
Dosimetric comparison of advanced radiation techniques for scalp-sparing in low-grade gliomas4
Risk factors for treatment-related sensorineural hearing loss and hearing aid use in medulloblastoma patients: an observational cohort study4
DEGRO 2024 Abstractband4
Effect of radiotherapy on the DNA cargo and cellular uptake mechanisms of extracellular vesicles4
Irradiation alters extracellular vesicle microRNA load in the serum of patients with leukaemia4
State-of-the-art application of nanoparticles in radiotherapy: a platform for synergistic effects in cancer treatment4
In memory of Univ.-Prof. Dr. med. Normann Willich (1946–2024)4
Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome4
Artificial intelligence for response prediction and personalisation in radiation oncology4
Präoperative Strahlentherapie und Pembrolizumab bei lokalisierten Weichteilsarkomen der Extremitäten: Ergebnisse der multizentrischen, randomisierten SU2C-SARC032-Studie4
Longer treatment time and lower radiation doses—an alternative for Graves’ ophthalmopathy treatment4
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell4
Die Bedeutung der Strahlentherapie im Kontext immer effektiver werdender Systemtherapien beim metastasierten NSCLC – Hinweise aus einer Rezidivanalyse nach Immuncheckpointinhibitoren4
Dose–effect relationship between dose–volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center4
Low doses to the heart in daily practice for treating left-sided breast cancer using accelerated partial-breast irradiation by multicatheter brachytherapy and deep-inspiration breath-hold using a SIB4
Correction to: Comparison of 3D and 4D Monte Carlo optimization in robotic tracking stereotactic body radiotherapy of lung cancer4
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation4
Influence of chemoradiation on the immune microenvironment of cervical cancer patients4
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients4
Radiochirurgie beim Nierenzellkarzinom: Daten der multizentrischen prospektiven FASTRACK II-Studie4
Deutlicher Überlebensvorteil durch simultane Radio- und Chemotherapie: Erkenntnisse aus einer chinesischen Phase-III-Studie bei älteren Patienten mit Ösophaguskarzinom4
0.1018488407135